|
Predictive Value of FOLFOX-Based Regimen, Long Interval, Hemoglobin Levels and Clinical Negative Nodal Status, and Postchemoradiotherapy CEA Levels for Pathological Complete Response in Patients with Locally Advanced Rectal Cancer after Neoadjuvant Chemor
|
20-03-10 |
|
Utilizing Experimental Mouse Model to Identify Effectors of Hepatocellular Carcinoma Induced by HBx Antigen
|
20-03-09 |
|
Combination of whole brain radiotherapy with epidermal growth factor receptor tyrosine kinase inhibitors improves overall survival in EGFR-mutated non-small cell lung cancer patients with brain metastases
|
20-02-10 |
|
Brain surgery in combination with tyrosine kinase inhibitor and whole brain radiotherapy for epidermal growth factor receptor-mutant non-small-cell lung cancer with brain metastases
|
20-02-10 |
|
Kinome-wide screening with small interfering RNA identified polo-like kinase 1 as a key regulator of proliferation in oral cancer cells
|
20-02-10 |
|
Manoalide Preferentially Provides Antiproliferation of Oral Cancer Cells by Oxidative Stress-Mediated Apoptosis and DNA Damage
|
20-02-10 |
|
Oxidative stress-modulating drugs have preferential anticancer effects - involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration.
|
20-02-10 |
|
Silencing of FOXA2 decreases E‐cadherin expression and is associated with lymph node metastasis in oral cancer
|
20-02-10 |
|
Phenoxyphenol Compound 4-HPPP Selectively Induces Antiproliferation Effects and Apoptosis in Human Lung Cancer Cells through Aneupolyploidization and ATR DNA Repair Signaling
|
20-02-10 |
|
Demonstration of melorheostosis on bone scan
|
20-02-10 |
|
Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma
|
20-02-10 |
|
Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast.
|
20-02-10 |
|
An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness
|
20-02-10 |
|
Surgical treatment following neoadjuvant chemoradiotherapy in locally advanced rectal cancer
|
20-02-05 |
|
Regorafenib plus FOLFIRI with irinotecan dose escalated according to uridine diphosphate glucuronosyltransferase 1A1genotyping in previous treated metastatic colorectal cancer patients: study protocol for a randomized controlled trial
|
20-02-05 |
|
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol
|
20-02-05 |
|
Orabase-formulated gentian violet effectively improved oral potentiallymalignant disorderin vitroandin vivo
|
20-01-19 |
|
Visfatin mediates malignant behaviors through adipose-derived stem cells intermediary in breast cancer
|
20-01-19 |
|
DNA Repair Protein Rad51 Induces Tumor Growth and Metastasis in Esophageal Squamous Cell Carcinoma via a p38/Akt-Dependent Pathway. Annals of Surgical Oncology
|
20-01-19 |
|
Manoalide Preferentially Provides Antiproliferation of Oral Cancer Cells by Oxidative Stress-Mediated Apoptosis and DNA Damage
|
20-01-19 |
|
C2-Ceramide-Induced Rb-Dominant Senescence-Like Phenotype Leads to Human Breast Cancer MCF-7 Escape from p53-Dependent Cell Death
|
20-01-19 |
